Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy

AIDS

Volumn 18, Issue 14, 2004, Pages 1953-1956

  Smith, Kimberly ^a   Aga, Evgenia ^b   Bosch, Ronald J ^b   Valdez, Hernan ^c   Connick, Elizabeth ^d   Landay, Alan ^e   Kuritzkes, Daniel ^f,g   Gross, Barry H ^h   Francis, Isaac R ^h   McCune, Joseph M ⁱ   Kessler, Harold ^a   Lederman, Michael ^j  

^a RUSH MEDICAL COLLEGE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^j UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOLOGIC AGENT; INDINAVIR; INTERLEUKIN 2; LAMIVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CELLULAR IMMUNITY; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE COURSE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LONG TERM CARE; LYMPHOCYTE COUNT; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES;

EID: 4744352698     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200409240-00012     Document Type: Article

References (9)

1. Lederman MM, Valdez H. Immune restoration with antiretroviral therapies - Implications for clinical management. JAMA 2000; 284:223-228.
2. Notermans DW, Pakker NG, Hamann D, Foudraine NA, Kauffmann RH, Meenhorst PL, et al. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. J Infect Dis 1999; 180:1050-1056.
3. Kaufmann GR, Bloch M, Finlayson R, Zaunders J, Smith D, Cooper DA. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 2002; 16:359-367.
4. Valdez H, Connick E, Smith KY, Lederman MM, Bosch RJ, Kim RS, et al. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 2002; 16:1859-1866.
5. Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carroll A, et al. The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy. AIDS 2003; 17:963-969.
6. Francis IR, Glazer GM, Bookstein FL, Gross BH. The thymus: reexamination of age-related thymus changes in size and shape. Am J Roentgenol 1985; 145:249-254.
7. Smith KY, Valdez H, Landay A, Spritzler J, Gross B, Francis I, et al. Thymic size and lymphocyte restoration in HIV infected patients following 48 weeks of therapy with zidovudine, lamivudine, and ritonavir. J Infect Dis 2000; 181:141-147.
8. Vigano A, Vella S, Saresella M, Vanzulli A, Bricalli D, Fabio S, et al. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS 2000; 14:251-261.
9. Rubio A, Martinez-Moya M, Leal M, Franco JM, Ruiz-Mateos E, Merchante E, et al. Changes in thymus volume in adult HIV-infected patients under HAART: correlation with the T-cell repopulation. Clin Exp Immunol 2002; 130:121-126.